Literature DB >> 18094458

Low hematocrit per blood viscosity ratio as a mortality risk factor in coronary heart disease.

P Kenyeres1, I Juricskay, P Tarsoly, G Kesmarky, D Mühl, K Toth, L Bogar.   

Abstract

Increased blood viscosity has not been associated with mortality risk in coronary heart disease (CHD). We aimed to investigate the predictive power of hematocrit per blood viscosity (Hct/BV) ratio as a marker of rheological oxygen carrying capacity of the blood to assess mortality risk of CHD. Elective coronary angiography was performed and CHD was proved in 109 patients in 1996 and 1997. In 78 cases (72%) complete follow up information was obtained in February 2006. During the follow up time (mean 8.9 years) 10 patients died due to cardiac cause (group C). Two patients died due to non-cardiac cause and 66 were still alive at the end of the follow up period (group NC, n=68). Mean hematocrit per blood viscosity (Hct/BV) ratio was significantly lower in group C comparing to NC (87+/-5; 93+/-9 Pa(-1)s(-1), SD, respectively, p=0.022). Other factors (body mass index, serum cholesterol, fibrinogen, hematocrit, plasma and blood viscosity, cardiac index, left ventricular ejection fraction) provided no statistical differences. Kaplan-Meier survival analysis showed only the impact of fibrinogen and Hct/BV ratio on cardiac mortality (p=0.029 and 0.009, respectively). Receiver operating characteristic curves proved only Hct/BV ratio to be able to differentiate between groups (area under curve: 0.716, p=0.028). Hct/BV ratio showed significant negative correlation with the frequency of hospital admissions (r=-0.377, p=0.03). Low Hct/BV ratio can be regarded as a risk factor of cardiac death in CHD.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18094458

Source DB:  PubMed          Journal:  Clin Hemorheol Microcirc        ISSN: 1386-0291            Impact factor:   2.375


  7 in total

Review 1.  Components of the complete blood count as risk predictors for coronary heart disease: in-depth review and update.

Authors:  Mohammad Madjid; Omid Fatemi
Journal:  Tex Heart Inst J       Date:  2013

2.  The role of hemorheological factors in cardiovascular medicine.

Authors:  A Toth; J Papp; M Rabai; P Kenyeres; Zs Marton; G Kesmarky; I Juricskay; H J Meiselman; K Toth
Journal:  Clin Hemorheol Microcirc       Date:  2014       Impact factor: 2.375

3.  Effect of testosterone undecanoate on hematological profiles, blood lipid and viscosity and plasma testosterone level in castrated rabbits.

Authors:  Chen Zhao; Du Geon Moon; Jong Kwan Park
Journal:  Can Urol Assoc J       Date:  2013 Mar-Apr       Impact factor: 1.862

Review 4.  The Mystery of Red Blood Cells Extracellular Vesicles in Sleep Apnea with Metabolic Dysfunction.

Authors:  Abdelnaby Khalyfa; David Sanz-Rubio
Journal:  Int J Mol Sci       Date:  2021-04-21       Impact factor: 5.923

5.  Hemorheology and microvascular disorders.

Authors:  Young-Il Cho; Daniel J Cho
Journal:  Korean Circ J       Date:  2011-06-30       Impact factor: 3.243

Review 6.  Mechanisms linking red blood cell disorders and cardiovascular diseases.

Authors:  Ioana Mozos
Journal:  Biomed Res Int       Date:  2015-02-01       Impact factor: 3.411

Review 7.  The Rheology of the Carotid Sinus: A Path Toward Bioinspired Intervention.

Authors:  Andrew Iskander; Coskun Bilgi; Rotem Naftalovich; Ilker Hacihaliloglu; Tolga Berkman; Daniel Naftalovich; Niema Pahlevan
Journal:  Front Bioeng Biotechnol       Date:  2021-06-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.